Former Sequenom R&D Chief Charged by SEC

The firm's former head of R&D, Elizabeth Dragon, was charged with making false statements to investors and analysts about Sequenom's test for Down syndrome.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.